ORCL Stock Drops 1.95% on Wednesday, Momentum Weakens

The Bollinger reading reinforces that caution. Price is at 20% of the band’s range, near the lower band at $118.34, while the band width has expanded to 20.2%. Wider bands indicate greater price volatility; they do not, by themselves, predict a rebound. The shares remain well below the middle band, which coincides with the 20-day average.

Oscillators & Momentum

The indicators offer a limited counterpoint to the falling trend. The Stochastic reading is oversold, with %K at 17.6 and %D at 15.4. “Oversold” means recent losses have been pronounced by this measure, but it does not establish that a bottom is in place. RSI at 42.6 is neutral, rather than signaling an extreme that would confirm an imminent reversal. MACD remains negative at -3.756, below its -3.382 signal line, with a negative histogram of -0.374. That combination points to downside momentum, not a confirmed turn. The technical-bias screen is bearish: three of seven bearish signals are present, with no bullish signals, including negative MACD momentum, price below the 50-day average in a downtrend, and falling OBV.

Volatility & Trading Activity

Volume reached 111,747,000 shares, versus a 20-day average of 41,733,015. Such a jump can accompany news-driven repositioning or intensified conviction; with OBV falling, the available evidence points toward distribution rather than accumulation. OBV tracks whether trading volume is more associated with buying or selling pressure over time. The 14-day ATR is $7.98, or 6.5% of the share price. ATR measures typical price movement, not direction. At this level, daily swings can be substantial, so the support area may be tested quickly if selling resumes.

Key Levels & Scenarios

The first test is $119.22, the 20-day support, with the three-month low at $118.43 close behind. A sustained break below those levels would put the chart’s lower boundary under pressure. If support holds, it could slow the decline, but a stronger repair would require the shares to reclaim the 20-day average at $131.65; resistance at $144.54 is a more distant hurdle. The nearest reference levels are not guarantees. Expanded Bollinger bands and elevated ATR mean that moves through support or resistance could be accompanied by wider swings.

Company Results & Filing Context

According to its SEC filing, Oracle reported quarterly revenue of $19.35 billion, up 29.6% from $14.93 billion a year earlier, for the quarter ended August 31, 2026. Net income was $4.76 billion, compared with $2.93 billion a year earlier, and diluted earnings per share were $1.56. Those results show strong reported growth, but the stock’s current technical signals reflect trading pressure, not a direct verdict on the company’s operating performance. Oracle also filed a Form 8-K with the SEC on November 4 reporting other material events.

Technical Verdict: SELL

The bearish verdict follows the supplied technical bias. The strongest evidence is the price below both moving averages, negative MACD momentum, and falling OBV alongside unusually heavy volume. The oversold Stochastic reading may allow for a bounce, but RSI remains neutral and does not confirm a reversal. - Illustrative entry range: $123.73–$131.65, spanning the latest price to the 20-day average. - Reference target: $119.22, the 20-day support; the next lower reference is the three-month low at $118.43. - Stop-loss reference: $144.54, the 20-day resistance. - Invalidation: the bearish verdict is invalidated if price breaks above $144.54. For non-traders, the chart currently shows more evidence of continued weakness than of a durable recovery, though support could interrupt the decline.

Summary Data ORCL

Last price	123.73 USD
Change 1 day / 5 days / 1 month	-1.95% / -14.40% / -13.81%
Trend / MA-cross	downtrend / none
SMA20 / SMA50	131.65 / 140.51
RSI (14) / Stochastic %K	42.6 / 17.6
Bollinger %B / ATR	20% / 7.98
Support / Resistance 20 days	119.22 / 144.54
Data as of	5 November 2026 04:03 WIB

Disclaimer: This technical analysis is generated automatically from exchange data and indicators calculated by JournalArta, for information and education only. The verdict and the entry, target and stop-loss levels are not investment advice or a solicitation to buy or sell any security. Investment decisions and their risks rest solely with the reader.

Track ORCL stock price daily: live levels, support/resistance and our full ORCL analysis history.